The Chemours Company
Balance Sheet
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $604.0M | $746.0M | $1.20B | $852.0M | $738.0M | $816.0M | $1.10B | $1.17B |
| Accounts Receivable | $788.0M | $692.0M | $509.0M | $753.0M | $782.0M | $722.0M | $509.0M | $844.0M |
| Inventory | $1.36B | $1.38B | $1.35B | $1.31B | $1.45B | $1.49B | $1.40B | $1.32B |
| Total Current Assets | $2.94B | $3.61B | $3.84B | $3.68B | $3.37B | $3.20B | $3.21B | $3.54B |
| Property, Plant & Equipment | $3.15B | $3.20B | $3.21B | $3.12B | $3.19B | $3.18B | $3.17B | $3.07B |
| Goodwill | $102.0M | $102.0M | $102.0M | $102.0M | $102.0M | $102.0M | $102.0M | $102.0M |
| Intangible Assets (Excl. Goodwill) | — | — | $3.0M | — | — | — | $13.0M | — |
| Total Assets | $7.25B | $7.98B | $8.24B | $7.95B | $7.66B | $7.62B | $7.64B | $7.75B |
| Liabilities | ||||||||
| Accounts Payable | $941.0M | $964.0M | $1.16B | $885.0M | $992.0M | $1.14B | $1.23B | $1.27B |
| Total Current Liabilities | $1.56B | $2.23B | $2.49B | $2.93B | $2.19B | $1.75B | $1.89B | $1.95B |
| Long-Term Debt | $3.95B | $3.97B | $3.99B | $3.94B | $3.60B | $3.60B | $3.59B | $3.51B |
| Total Liabilities | $6.53B | $7.23B | $7.52B | $7.20B | $6.85B | $6.40B | $6.53B | $6.46B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $1.82B | $1.80B | $1.78B | $1.84B | $1.86B | $2.28B | $2.17B | $2.30B |
| Total Stockholders' Equity | $714.0M | $753.0M | $721.0M | $755.0M | $808.0M | $1.23B | $1.11B | $1.28B |